New press release out today, celebrating the tremendous efforts of our business development and research teams.
FOR IMMEDIATE RELEASE
March 9, 2009 (CHAPEL HILL, NC) Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces on-going research and consulting work for seven of the world’s largest pharmaceutical companies.
After record-setting business development efforts during the fourth quarter of 2009, the research team at Thought Leader Select has commenced the study of over 1300 KOLs across 10 therapeutic areas and 14 disease states in the United States and Canada. Employing its industry-leading “deep-profiling” methodology, the team at Thought Leader Select is matching key opinion leaders, based on their skills and experiences, with pharmaceutical partners for key roles in clinical trials, advisory boards, and treatment guidelines.
The KOLs represent the therapeutic areas of cardiac surgery, cardiology, general surgery, hematology, ophthalmology, rheumatology, endocrinology, infectious diseases, dermatology, and gastroenterology. In addition to its signature work with physician KOLs, Thought Leader Select is also delivering key research on institutional KOLs, such as pharmacy directors, directors of hospital medicine, and internal medicine specialists, as well as nurse practitioners and physician assistants.
Rounding out Thought Leader Select’s current project list is another of its landmark Centers of Excellence studies, with the current casework focused on the top cardiac centers in North America.
“Our current projects in-process really demonstrate the versatility of our research team,” said Lisa Smith, executive vice president of research at Thought Leader Select. “We are showing the real breadth and depth of our capabilities in assisting pharmaceutical companies with engaging and deploying KOLs more effectively.”
About Thought Leader Select
Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice—for more effective key opinion leader (KOL) engagement and deployment. Thought Leader Select’s groundbreaking work bridges the areas of research, communications, and technology. With more than 70 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.
Vice President of Marketing & Planning